Analytical quality by design for gas chromatographic method development

Abstract Quality by design (QbD) is a scientific approach in pharmaceutical product development beginning with predefined goals and utilizes scientific knowledge and risk management tools to understand the process/product and finally process control. The change in mindset of a research professional from quality by testing to QbD is a significant trend in analytical sciences for the future. QbD has the potential to be extended to analytical techniques such as gas chromatography (GC) to achieve optimum analytical method performance. GC is a sensitive, consistent, and versatile technique applied to analyze complex mixtures and drugs as well as pharmaceutical products. Application of analytical QbD principles to GC encompasses all the essential steps including GC method development and validation. This chapter outlines the application of QbD concepts to analytical separation method of GC along with utilization of risk assessment and design of experiments. It further offers a greater understanding and recognition of GC variables influencing the performance of its method enabling an enhancement in quality.

[1]  Sandra Furlanetto,et al.  Development of a capillary electrophoresis method for the assay of ramipril and its impurities: an issue of cis-trans isomerization. , 2011, Journal of chromatography. A.

[2]  Z. Z. Sultanov Production of lithocholic acid by partial synthesis , 2004, Pharmaceutical Chemistry Journal.

[3]  Sandra Furlanetto,et al.  Application of quality by design to the development of analytical separation methods , 2012, Analytical and Bioanalytical Chemistry.

[4]  Frederick G. Vogt,et al.  A Systematic Method Development Strategy for Quantitative Color Measurement in Drug Substances, Starting Materials, and Synthetic Intermediates , 2011, Journal of Pharmaceutical Innovation.

[5]  Ntsomboh-Ntsefong Godswill,et al.  GC-FID Method Development and Validation Parameters for Analysis of Palm Oil ( Elaeis guineensis Jacq.) Fatty Acids Composition , 2014 .

[6]  Marion J. Chatfield,et al.  Design and analysis of method equivalence studies. , 2009, Analytical chemistry.

[7]  Hardik Patel,et al.  A Comprehensive Review on Quality by Design (QbD) in Pharmaceuticals , 2013 .

[8]  Vicki J. Barwick,et al.  Sources of uncertainty in gas chromatography and high-performance liquid chromatography , 1999 .

[9]  N. Vishal Gupta,et al.  A Review on quality by design approach (QBD) for Pharmaceuticals , 2015 .

[10]  Sagar Suman Panda,et al.  Implementation of Quality by Design Approach for Developing Chromatographic Methods with Enhanced Performance: A Mini Review , 2016 .

[11]  Mahfoozur Rahman,et al.  Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products. , 2019, Drug discovery today.

[12]  M. Klee,et al.  Theoretical and practical aspects of fast gas chromatography and method translation. , 2002, Journal of chromatographic science.

[13]  S. Dubey,et al.  QbD-driven development and validation of HPLC method for determination of Bisphenol A and Bis-sulphone in environmental samples , 2020, International Journal of Environmental Analytical Chemistry.

[14]  E. Rozet,et al.  Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space. , 2011, Journal of chromatography. A.

[15]  Bernard A Olsen,et al.  A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603). , 2008, Journal of pharmaceutical and biomedical analysis.

[16]  Frederick G Vogt,et al.  Development of quality-by-design analytical methods. , 2011, Journal of pharmaceutical sciences.

[17]  S Furlanetto,et al.  Mixture-process variable approach to optimize a microemulsion electrokinetic chromatography method for the quality control of a nutraceutical based on coenzyme Q10. , 2012, Talanta.

[18]  Sandra Furlanetto,et al.  Pitfalls and success of experimental design in the development of a mixed MEKC method for the analysis of budesonide and its impurities , 2009, Electrophoresis.

[19]  Sarwar Beg,et al.  Pharmaceutical QbD: Omnipresence in the product development lifecycle , 2017 .

[20]  B. Shapiro,et al.  Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method , 2019, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[21]  Av Ganorkar,et al.  Analytical Quality by Design: A Mini Review , 2017 .

[22]  P. Marriott,et al.  Influence of chromatographic conditions on separation in comprehensive gas chromatography. , 2002, Journal of chromatography. A.

[23]  Simon J. Bale,et al.  Quality by Design for Analytical Methods , 2010 .

[24]  Sharmada S. Sinai Kakodkar,et al.  Pharmaceutical Quality-by-Design (QbD): Basic Principles , 2015 .

[25]  O. Coskun Separation techniques: Chromatography , 2016, Northern clinics of Istanbul.

[26]  David Q. Liu,et al.  A Systematic Method Development Strategy for Determination of Pharmaceutical Genotoxic Impurities , 2010 .

[27]  Suman Sood,et al.  Method development and validation using HPLC technique – A review , 2014 .

[28]  G. L. Reid,et al.  REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT IN AN ANALYTICAL QUALITY BY DESIGN FRAMEWORK , 2013 .

[29]  B. Jahnavi,et al.  QbD Considerations for Analytical Development , 2019, Pharmaceutical Quality by Design.

[30]  T. Kupiec Quality-control analytical methods: gas chromatography. , 2004, International journal of pharmaceutical compounding.

[31]  A. Welankiwar,et al.  Method development by liquid chromatography with validation , 2014 .

[32]  Nafisur Rahman,et al.  Analytical techniques in pharmaceutical analysis: A review , 2017 .

[33]  Ramalingam Peraman,et al.  Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics , 2015, International journal of analytical chemistry.

[34]  A. Parczewski,et al.  Analytical methods for residual solvents determination in pharmaceutical products. , 2010, Acta poloniae pharmaceutica.

[35]  S. Dubey,et al.  Pre-clinical pharmacokinetic-pharmacodynamic modelling and biodistribution studies of donepezil hydrochloride by a validated HPLC method , 2018, RSC advances.

[36]  I. Molnár,et al.  Aspects of the "Design Space" in high pressure liquid chromatography method development. , 2010, Journal of chromatography. A.

[37]  Ashish Chauhan,et al.  GC-MS Technique and its Analytical Applications in Science and Technology , 2014 .

[38]  S. Dubey,et al.  Rapid and Sensitive Reverse-phase High-performance Liquid Chromatography Method for Estimation of Ketorolac in Pharmaceuticals Using Weighted Regression , 2013, Indian journal of pharmaceutical sciences.

[39]  J. S. Hunter,et al.  The 2 k — p Fractional Factorial Designs , 1961 .

[40]  P. Borman,et al.  Acceptance criteria for method equivalency assessments. , 2009, Analytical chemistry.

[41]  V. Gupta,et al.  HPLC : Isocratic or Gradient Elution and Assessment of Linearity In Analytical Methods , 2012 .